Fifth Third Wealth Advisors LLC Grows Position in UnitedHealth Group Incorporated (NYSE:UNH)

by · The Markets Daily

Fifth Third Wealth Advisors LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 15.3% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 12,018 shares of the healthcare conglomerate’s stock after buying an additional 1,594 shares during the period. Fifth Third Wealth Advisors LLC’s holdings in UnitedHealth Group were worth $7,027,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. bought a new position in shares of UnitedHealth Group in the third quarter worth $27,000. Macroview Investment Management LLC lifted its position in UnitedHealth Group by 671.4% in the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC bought a new position in UnitedHealth Group during the 2nd quarter worth approximately $31,000. Global Wealth Strategies & Associates lifted its position in UnitedHealth Group by 152.4% in the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after purchasing an additional 32 shares during the last quarter. Finally, Signature Resources Capital Management LLC grew its holdings in shares of UnitedHealth Group by 40.0% in the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock worth $32,000 after purchasing an additional 18 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Trading Down 0.4 %

Shares of UnitedHealth Group stock opened at $589.65 on Tuesday. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company’s fifty day simple moving average is $582.75 and its 200-day simple moving average is $550.66. The stock has a market capitalization of $542.64 billion, a PE ratio of 38.41, a P/E/G ratio of 1.74 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the previous year, the firm earned $6.56 EPS. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Investors of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. TD Cowen upped their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. KeyCorp assumed coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. Bank of America lowered their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Stephens lowered their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Finally, Truist Financial reissued a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $615.53.

Get Our Latest Report on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).